A patient with central nervous system tuberculomas and a history of disseminated multi-drug-resistant tuberculosis.
J Clin Tuberc Other Mycobact Dis
; 10: 9-16, 2018 Jan.
Article
em En
| MEDLINE
| ID: mdl-31720380
ABSTRACT
Tuberculosis (TB) is one of the leading causes of death worldwide, particularly in low- and middle-income countries. The global rates and numbers of drug resistant TB are rising. With increasing globalization, the spread of drug-resistant strains of TB has become a mounting global public health concern. We present a case of a young man previously treated for multi-drug resistant (MDR) TB in India who presented with neurological symptoms and central nervous system TB in the United States. His case highlights unique diagnostic and treatment challenges that are likely to become more commonplace with the increase of patients infected with drug-resistant TB and complicated extrapulmonary disease.
AFB, acid-fast bacilli; BAL, bronchoalveolar lavage; Bedaquiline; CNS, central nervous system; CSF, cerebrospinal fluid; CT, computerized tomography; Central nervous system (CNS) TB; DOT, directly observed therapy; DST, drug susceptibility testing; Extensively drug-resistant tuberculosis (XDR-TB); FDA, Food and Drug Administration; IV, intravenous; LUL, left upper lobe; MDR-TB, multidrug-resistant tuberculosis; MRI, magnetic resonance imaging; Multi-drug resistant tuberculosis (MDR-TB); TB, tuberculosis; Tuberculoma; Tuberculosis (TB); WHO, World Health Organization; XDR-TB, extensively drug-resistant tuberculosis
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
J Clin Tuberc Other Mycobact Dis
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
Estados Unidos